Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells.
Gazzano M, Parizot C, Psimaras D, Vozy A, Baron M, Abbar B, Fallet V, Litvinova E, Canellas A, Birzu C, Pourcher V, Touat M, Weiss N, Demeret S, Roos-Weil D, Spano JP, Lebbe C, Salem JE, Cadranel J, Hervier B, Gorochov G, Guihot A.
Gazzano M, et al. Among authors: guihot a.
Front Immunol. 2022 Dec 20;13:1082084. doi: 10.3389/fimmu.2022.1082084. eCollection 2022.
Front Immunol. 2022.
PMID: 36605194
Free PMC article.